Vorschau! Die Detailseite für diese Publikation wurde nicht aktiviert!
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
mehr| Titel | Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis |
|---|---|
| Medien | Breast Cancer Research and Treatment |
| Heft | 2 |
| Band | 173 |
| Verfasser | Peter A. Fasching, Andreas D. Hartkopf, Paul Gass, Lothar Häberle, Leyla Akpolat-Basci, Alexander Hein, Prof. Dr. Bernhard Volz, .. et al., Hans-Christian Kolberg |
| Seiten | 319-328 |
| Veröffentlichungsdatum | 31.01.2019 |
| Zitation | Fasching, Peter A.; Hartkopf, Andreas D.; Gass, Paul; Häberle, Lothar; Akpolat-Basci, Leyla; Hein, Alexander; Volz, Bernhard; et al., ..; Kolberg, Hans-Christian (2019): Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis. Breast Cancer Research and Treatment 173 (2), 319-328. DOI: 10.1007/s10549-018-5008-3 |